HIV Research Lab's Future Threatened

Targeted by the Trump administration, an HIV research lab that relies on fetal tissue from elective abortions faces an uncertain future.
Last week, the NIH notified the University of California at San Francisco research center—which has played an instrumental role in testing nearly all HIV therapies approved by the FDA—that the government plans to end its contract early, based on a decision from the “highest levels.”
Congressional conservatives and antiabortion activists charge that fetal tissue research uses “body parts” from “unborn babies,” and say that alternatives exist. But scientists like Stanford stem cell researcher Irving Weissman say the research method is vital—and without substitute.

The Washington Post

Comments +


Post a Comment

Restricted HTML

  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Back to top